Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.43 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.34 |
| ▸ | PRKCG | P05129 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5909391 | 0.80 | MAP3K14 (0.55) | MAP3K14CRBNCYP19A1IDO1 | |
| SCHEMBL11103792 | 0.74 | CA1 (0.36) | MAP3K14CRBNPTPN1PRKCG | |
| SCHEMBL24490044 | 0.70 | MAP3K14 (0.44) | MAP3K14CRBNCYP19A1IDO1 | |
| SCHEMBL18643159 | 0.68 | MAP3K14 (0.48) | MAP3K14CRBNCYP19A1IDO1 | |
| SCHEMBL6897659 | 0.67 | — | — | |
| SCHEMBL8499277 | 0.67 | — | — | |
| SCHEMBL11719476 | 0.67 | MAP3K14 (0.46) | MAP3K14CRBNCYP19A1 | |
| SCHEMBL27815633 | 0.65 | GLA (0.41) | MAP3K14CRBNCYP19A1 | |
| SCHEMBL31536451 | 0.63 | MAP3K14 (0.31) | MAP3K14 | |
| SCHEMBL2958336 | 0.63 | MAP3K14 (0.42) | MAP3K14CRBNCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1425443-A1 | BRANCHED POLY(ETHYLENE TEREPHTHALATE) MONOFILAMENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-06-09 | — | — | EP | disclosed |
| WO-2003014439-A1 | BRANCHED POLY(ETHYLENE TEREPHTHALATE) MONOFILAMENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-02-20 | — | — | WO | disclosed |